Valentina Zuco
Fondazione IRCCS Istituto Nazionale dei Tumori(IT)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Epigenetics and DNA Methylation, Chronic Myeloid Leukemia Treatments, Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms
Most-Cited Works
- → Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells(2002)524 cited
- → Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents(2017)245 cited
- → Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells(2013)103 cited
- → Exosome-like Nanovectors for Drug Delivery in Cancer(2018)100 cited
- → miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis(2017)96 cited
- → The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition(2009)83 cited
- → miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition(2019)72 cited
- → Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells(2001)72 cited
- → Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors(2008)63 cited
- → RETRACTED: Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo(2011)62 cited